Abeona Therapeutics Statistics
Total Valuation
ABEO has a market cap or net worth of $343.10 million. The enterprise value is $216.15 million.
| Market Cap | 343.10M |
| Enterprise Value | 216.15M |
Important Dates
The last earnings date was Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ABEO has 57.18 million shares outstanding. The number of shares has decreased by -1.73% in one year.
| Current Share Class | 57.18M |
| Shares Outstanding | 57.18M |
| Shares Change (YoY) | -1.73% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 16.16% |
| Owned by Institutions (%) | 49.51% |
| Float | 36.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.44 |
| Forward PS | 4.15 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 2.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.63, with a Debt / Equity ratio of 0.16.
| Current Ratio | 6.63 |
| Quick Ratio | 6.32 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.25 |
Financial Efficiency
Return on equity (ROE) is -43.13% and return on invested capital (ROIC) is -17,696.30%.
| Return on Equity (ROE) | -43.13% |
| Return on Assets (ROA) | -24.55% |
| Return on Invested Capital (ROIC) | -17,696.30% |
| Return on Capital Employed (ROCE) | -54.05% |
| Weighted Average Cost of Capital (WACC) | 11.62% |
| Revenue Per Employee | $112,920 |
| Profits Per Employee | -$278,261 |
| Employee Count | 226 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 8.30 |
Taxes
| Income Tax | -15.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.67% in the last 52 weeks. The beta is 1.32, so ABEO's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -13.67% |
| 50-Day Moving Average | 6.42 |
| 200-Day Moving Average | 5.50 |
| Relative Strength Index (RSI) | 44.32 |
| Average Volume (20 Days) | 1,570,860 |
Short Selling Information
The latest short interest is 14.27 million, so 24.96% of the outstanding shares have been sold short.
| Short Interest | 14.27M |
| Short Previous Month | 13.64M |
| Short % of Shares Out | 24.96% |
| Short % of Float | 38.77% |
| Short Ratio (days to cover) | 9.43 |
Income Statement
In the last 12 months, ABEO had revenue of $25.52 million and -$62.89 million in losses. Loss per share was -$1.18.
| Revenue | 25.52M |
| Gross Profit | -10.18M |
| Operating Income | -83.62M |
| Pretax Income | -78.30M |
| Net Income | -62.89M |
| EBITDA | -80.79M |
| EBIT | -83.62M |
| Loss Per Share | -$1.18 |
Balance Sheet
The company has $146.83 million in cash and $19.87 million in debt, with a net cash position of $126.95 million or $2.22 per share.
| Cash & Cash Equivalents | 146.83M |
| Total Debt | 19.87M |
| Net Cash | 126.95M |
| Net Cash Per Share | $2.22 |
| Equity (Book Value) | 128.06M |
| Book Value Per Share | 2.24 |
| Working Capital | 139.77M |
Cash Flow
In the last 12 months, operating cash flow was -$76.44 million and capital expenditures -$5.09 million, giving a free cash flow of -$81.53 million.
| Operating Cash Flow | -76.44M |
| Capital Expenditures | -5.09M |
| Depreciation & Amortization | 2.83M |
| Net Borrowing | -5.56M |
| Free Cash Flow | -81.53M |
| FCF Per Share | -$1.43 |
Margins
Gross margin is -39.90%, with operating and profit margins of -327.64% and -246.42%.
| Gross Margin | -39.90% |
| Operating Margin | -327.64% |
| Pretax Margin | -306.81% |
| Profit Margin | -246.42% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ABEO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.73% |
| Shareholder Yield | 1.73% |
| Earnings Yield | -18.33% |
| FCF Yield | -23.76% |
Analyst Forecast
The average price target for ABEO is $18.86, which is 214.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.86 |
| Price Target Difference | 214.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 213.73% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 5, 2022. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jul 5, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ABEO has an Altman Z-Score of -3.11 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.11 |
| Piotroski F-Score | 3 |